Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment
The pharmaceutical company behind a drug that's been approved by the Food and Drug Administration for emergency use for covid-19 patients announced today the drug will cost $3,120 per typical treatment course for individuals with private insurance plans.